Sun Pharma posts Rs 2,227 crore net loss in Q4 of 2021-22 \
2 min read
\
\

Sun Pharma posts Rs 2,227 crore net loss in Q4 of 2021-22

30-May-2022
Mumbai (Maharashtra) [India], May 30 (ANI): Sun Pharmaceuticals Industries on Monday reported a consolidated net loss of Rs 2,227.38 crore for the quarter ended March 2022 as against a net profit of Rs 848 crore recorded in the corresponding period of the previous year, hit by one-time charges on settlement of a pending litigation in the US.
30-May-2022 Business
\